<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nogr</journal-id><journal-title-group><journal-title xml:lang="ru">Экспериментальная и клиническая гастроэнтерология</journal-title><trans-title-group xml:lang="en"><trans-title>Experimental and Clinical Gastroenterology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-8658</issn><publisher><publisher-name>«Global Media Technologies»</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">nogr-578</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЛЕКЦИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>LECTION</subject></subj-group></article-categories><title-group><article-title>МЕТАБИОТИКИ - НОВАЯ ТЕХНОЛОГИЯ ПРОФИЛАКТИКИ И ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С МИКРОЭКОЛОГИЧЕСКИМИ НАРУШЕНИЯМИ В ОРГАНИЗМЕ ЧЕЛОВЕКА</article-title><trans-title-group xml:lang="en"><trans-title>METABIOTICS - NOVEL TECHNOLOGY OF PROTECTIVE AND TREATMENT OF DISEASES ASSOCIATED WITH MICROECOLOGICAL IMBALANCE IN HUMAN BEING</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шендеров</surname><given-names>Б. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Shenderov</surname><given-names>B. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ткаченко</surname><given-names>Е. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Tkachenko</surname><given-names>E. I.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лазебник</surname><given-names>Л. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Lazebnik</surname><given-names>L. B.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ардатская</surname><given-names>М. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Ardatskaya</surname><given-names>M. D.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Синица</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Sinitsa</surname><given-names>A. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-5"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Захарченко</surname><given-names>М. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Zakharchenko</surname><given-names>M. M.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-5"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>«ЦСП» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Center for Strategic Planning Russian Ministry of Health</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Военно-медицинская академия им. С. М. Кирова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>SM Kirov Military Medical Academy</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Московский государственный медико-стоматологический университет им. А. И. Евдокимова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>AI Evdokimov Moscow State Medical-Stomatological University, Ministry of Health</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>Центральная государственная медицинская академия Управления делами Президента РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Central State Medical Academy</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-5"><aff xml:lang="ru"><institution>ООО «Крафт»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Kraft LLC</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>20</day><month>03</month><year>2018</year></pub-date><volume>0</volume><issue>3</issue><fpage>83</fpage><lpage>92</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Шендеров Б.А., Ткаченко Е.И., Лазебник Л.Б., Ардатская М.Д., Синица А.В., Захарченко М.М., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Шендеров Б.А., Ткаченко Е.И., Лазебник Л.Б., Ардатская М.Д., Синица А.В., Захарченко М.М.</copyright-holder><copyright-holder xml:lang="en">Shenderov B.A., Tkachenko E.I., Lazebnik L.B., Ardatskaya M.D., Sinitsa A.V., Zakharchenko M.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.nogr.org/jour/article/view/578">https://www.nogr.org/jour/article/view/578</self-uri><abstract><p>Взаимодействие между организмом и его симбиотической микробиотой связано с низкомолекулярными микробными соединениями, способными активировать, ингибировать, модифицировать процессы, функции и реакции различных органов и тканей. Дефицит или нарушение их состава приводит к дисбалансу митохондриальных, микробных и клеточных метаболитов, что может явиться фактором риска метаболических заболеваний. Наиболее распространенным приемом сохранения и восстановления микробиоценозов человека являются пробиотики и пребиотики. К сожалению, благоприятные эффекты пробиотиков, изготовленных на основе живых микроорганизмов, часто кратковременны, неопределенные или отсутствуют полностью; традиционные пробиотики могут также вызывать различные побочные эффекты при их применении. В последние годы в качестве новых приемов поддержания и восстановления микробной экологии человека начинают использовать метабиотики (М). М являются структурными компонентами пробиотических микроорганизмов, и/или их метаболитов, и/или сигнальных молекул с определенной (известной) химической структурой, которые способны оптимизировать специфичные для организма-хозяина физиологические функции, метаболические, эпигенетические, информационные, регуляторные, транспортные и/или поведенческие реакции, связанные с деятельностью симбиотической микробиоты. М могут выступать как самостоятельные средства, так и в качестве обогащающих добавок функциональных продуктов питания. Последующие генерации полусинтетических, синтетических и гибридных М могут стать аналогами или улучшенными копиями природных микробных низкомолекулярных соединений.</p></abstract><trans-abstract xml:lang="en"><p>The human symbiotic microbiota produces various bio-active molecules having chemical and functional similarity to dietary nutrients and /or endogenous compounds. Various factors and agents cause the imbalance of host/microbial dialogue. Currently for conservation and restoration of human microbial community various probiotics and prebiotics are used. Unfortunately, probiotic effects are often short term or absent or uncertain; traditional probiotics may also have non-desirable side effects in the application. For these reasons, the search for microbial molecule modifiers of host/microbe axis is emerging, especially with regard to personal medicine. These compounds have been named metabiotics (M). M are structural components of known probiotic microorganisms and/or their metabolites and/or signaling molecules that can restoring shortages and disruption of the balance of mitochondrial, microbial or cellular LMW substances with increased health effectiveness. They have some advantages (certain chemical structure, well dosed, safety, long shelf-life) in optimizing host gene expression, epigenetic, energetic, metabolic, immune, informational, regulatory, transport, neuro-hormonal and/or behavioral responses associated with the symbiotic microbiota. M can act as independent means or as enriching additives in functional foods. Simple microbial molecules can also be used in constructing hybrid M containing multiple metabolites and structural components separately or in combination with herbal compounds. Special attention should be paid to the design of M with specific targets in the host. Further investigations will clarify what natural microbial or artificial (semi-synthetic, synthetic, hybolite) pan- or selective M may affect host functions, biochemical and signal processes.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>пробиотические микроорганизмы</kwd><kwd>низкомолекулярные биоактивные молекулы</kwd><kwd>микробные структурные компоненты</kwd><kwd>метаболиты</kwd><kwd>сигнальные молекулы</kwd><kwd>простые и сложные гибридные метабиотики</kwd></kwd-group><kwd-group xml:lang="en"><kwd>microbe/host cross talk</kwd><kwd>probiotic microorganisms</kwd><kwd>bioactive molecules</kwd><kwd>microbial structural components</kwd><kwd>metabolites</kwd><kwd>signaling molecules</kwd><kwd>simple and complex hybrid metabiotics</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ugolev A. M. Teoriya adekvatnogo pitaniya i Trofologiya- L. Nauka, 1991. - 372 s.</mixed-citation><mixed-citation xml:lang="en">Ugolev A. M. Teoriya adekvatnogo pitaniya i Trofologiya- L. Nauka, 1991. - 372 s.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Lederberg J. Infectious history. Science 2000; 288: 287-289.</mixed-citation><mixed-citation xml:lang="en">Lederberg J. Infectious history. Science 2000; 288: 287-289.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Tkachenko E. I. Paradigma disbioza v sovremennoy gastroenterologii. Rol’ mikrobioty v lechenii i profilaktike zabolevaniy v XXI veke. Eksperimental’naya i klinicheskaya gastroenterologiya. 2014; 105(5):4-7.</mixed-citation><mixed-citation xml:lang="en">Tkachenko E. I. Paradigma disbioza v sovremennoy gastroenterologii. Rol’ mikrobioty v lechenii i profilaktike zabolevaniy v XXI veke. Eksperimental’naya i klinicheskaya gastroenterologiya. 2014; 105(5):4-7.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Prescott SL. History of medicine: Origin of the term microbiome and why it matterns. Human Microbiome Journal 2017; 4: 24-25.</mixed-citation><mixed-citation xml:lang="en">Prescott SL. History of medicine: Origin of the term microbiome and why it matterns. Human Microbiome Journal 2017; 4: 24-25.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Shenderov B. A., Sinitsa A. V., Zakharchenko M. M. Metabiotiki: vchera, segodnya, zavtra. Sankt-Peterburg. OOO “Kraft”, 2017. - 80 s.</mixed-citation><mixed-citation xml:lang="en">Shenderov B. A., Sinitsa A. V., Zakharchenko M. M. Metabiotiki: vchera, segodnya, zavtra. Sankt-Peterburg. OOO “Kraft”, 2017. - 80 s.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Shenderov B. A. Modern condition and prospective host microecology investigations. Microb Ecol Health Dis 2007; 19: 145-149.</mixed-citation><mixed-citation xml:lang="en">Shenderov B. A. Modern condition and prospective host microecology investigations. Microb Ecol Health Dis 2007; 19: 145-149.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Shenderov B. A. Mikrobnaya ekologiya cheloveka i yeye rol’ v podderzhanii zdorov’ya. METAFORMOZY. 2014; № 5:72-80.</mixed-citation><mixed-citation xml:lang="en">Shenderov B. A. Mikrobnaya ekologiya cheloveka i yeye rol’ v podderzhanii zdorov’ya. METAFORMOZY. 2014; № 5:72-80.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Shenderov B. A. Metabiotiki - novaya tekhnologiya profilaktiki zabolevaniy, svyazannykh s mikroekologicheskim disbalansom cheloveka. Vestnik vosstanovitel’noy meditsiny 2017; № 4: 40-49.</mixed-citation><mixed-citation xml:lang="en">Shenderov B. A. Metabiotiki - novaya tekhnologiya profilaktiki zabolevaniy, svyazannykh s mikroekologicheskim disbalansom cheloveka. Vestnik vosstanovitel’noy meditsiny 2017; № 4: 40-49.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Li J, Jia H, Cai X, Zhong H, Feng Q, Sunagawa S. et al. An Integrated catalog of reference genes in the human gut microbiome. Nat Biotechnol 2014; 32: 834-41.</mixed-citation><mixed-citation xml:lang="en">Li J, Jia H, Cai X, Zhong H, Feng Q, Sunagawa S. et al. An Integrated catalog of reference genes in the human gut microbiome. Nat Biotechnol 2014; 32: 834-41.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Gaci N., mBorrel G., Tottey W., O’Toole PW, Brugere J-F. Archaea and the human gut: New beginning of an old story. World Journal of Gastroenterology 2014; 20(43): 16062-16078.</mixed-citation><mixed-citation xml:lang="en">Gaci N., mBorrel G., Tottey W., O’Toole PW, Brugere J-F. Archaea and the human gut: New beginning of an old story. World Journal of Gastroenterology 2014; 20(43): 16062-16078.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Ardatskaya M. D., Bel’mer S. V., Dobritsa V. P., Zakharenko S. M., Lazebnik L. B., Minushkin O. N., Oreshko L. S, Sitkin S. I., Tkachenko E. I., Suvorov A. N., Khavkin A. I., Shenderov B. A. Disbioz (disbakterioz) kishechnika: sovremennoye sostoyaniye problemy, kompleksnaya diagnostika i lechebnaya korrektsiya. Eksperimental’naya i klinicheskaya gastroenterologiya 2015; 117 (5):13-50.</mixed-citation><mixed-citation xml:lang="en">Ardatskaya M. D., Bel’mer S. V., Dobritsa V. P., Zakharenko S. M., Lazebnik L. B., Minushkin O. N., Oreshko L. S, Sitkin S. I., Tkachenko E. I., Suvorov A. N., Khavkin A. I., Shenderov B. A. Disbioz (disbakterioz) kishechnika: sovremennoye sostoyaniye problemy, kompleksnaya diagnostika i lechebnaya korrektsiya. Eksperimental’naya i klinicheskaya gastroenterologiya 2015; 117 (5):13-50.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Falony G., Joossens M., Viera-Silva S., Wang J., Darzi Y., Faust K., Kurilshikov A., Bonder M. J., Valles-Colomer M., Vandeputte D, Tito RY, Chaffron S., Rymenans L. et al. Population-level analysis of gut microbiome variation. Science 2016; 352 (6285): 560-564; DOI: 10.1126/science.aad3503.</mixed-citation><mixed-citation xml:lang="en">Falony G., Joossens M., Viera-Silva S., Wang J., Darzi Y., Faust K., Kurilshikov A., Bonder M. J., Valles-Colomer M., Vandeputte D, Tito RY, Chaffron S., Rymenans L. et al. Population-level analysis of gut microbiome variation. Science 2016; 352 (6285): 560-564; DOI: 10.1126/science.aad3503.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Zhernakova A, Kurilshikov A, Bonder M. J., Tigchelaar EF, Schirmer M, Vatanen T. et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science 2016; 352: 565-569.</mixed-citation><mixed-citation xml:lang="en">Zhernakova A, Kurilshikov A, Bonder M. J., Tigchelaar EF, Schirmer M, Vatanen T. et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science 2016; 352: 565-569.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Proal A. D., Lindseth I.A, Marshall T. G. Microbe-Microbe and Host- Microbe Interactions Drive Microbiome Dysbiosis and Inflammatory Processes. Discovery Medicine 2017; 23(124): 51-60.</mixed-citation><mixed-citation xml:lang="en">Proal A. D., Lindseth I.A, Marshall T. G. Microbe-Microbe and Host- Microbe Interactions Drive Microbiome Dysbiosis and Inflammatory Processes. Discovery Medicine 2017; 23(124): 51-60.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Blum HE. The human microbiome. Advance in Medical Sciences 2017;62:414-20.http://dx.doi.org/10.1016/j.advms.2017.04.005.</mixed-citation><mixed-citation xml:lang="en">Blum HE. The human microbiome. Advance in Medical Sciences 2017;62:414-20.http://dx.doi.org/10.1016/j.advms.2017.04.005.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Bik E. M., Ugalde J. A., Cousins J., Goddard A. D., Richman J., Apte Z. S. Microbial biotransformations in the human distal gut. British J Pharmacology 2017. DOI:10.1111/bph.14085.</mixed-citation><mixed-citation xml:lang="en">Bik E. M., Ugalde J. A., Cousins J., Goddard A. D., Richman J., Apte Z. S. Microbial biotransformations in the human distal gut. British J Pharmacology 2017. DOI:10.1111/bph.14085.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Sonnenburg JL, Backhed F. Diet-microbiota interactions as moderators of human metabolism. Nature 2016; 536: 56-64.</mixed-citation><mixed-citation xml:lang="en">Sonnenburg JL, Backhed F. Diet-microbiota interactions as moderators of human metabolism. Nature 2016; 536: 56-64.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Badretdinova L. M., Batregdinova R. R., Shenderov B. A. Sanatorno-kurortnoye lecheniye osteoartroza. Sovremennoye sostoyaniye i perspektivy. Yekaterinborg.: Izdatel’stvo AMB, 2012. - S. 99-117.</mixed-citation><mixed-citation xml:lang="en">Badretdinova L. M., Batregdinova R. R., Shenderov B. A. Sanatorno-kurortnoye lecheniye osteoartroza. Sovremennoye sostoyaniye i perspektivy. Yekaterinborg.: Izdatel’stvo AMB, 2012. - S. 99-117.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Shenderov B. A. Probiotic (symbiotic) bacterial languages. Anaerobe 2011; 17: 490-495.</mixed-citation><mixed-citation xml:lang="en">Shenderov B. A. Probiotic (symbiotic) bacterial languages. Anaerobe 2011; 17: 490-495.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Shenderov BA. PROBIOTICS AND FUNCTIONAL FOODS, in Food Engineering, [Eds. UNESCO-EOLSS Joint Committee], in Encyclopedia of Life Support Systems (EOLSS), Developed under the Auspices of the UNESCO, Eolss Publishers, Oxford, UK, [http://www.eols.net]. 2011; 33p.</mixed-citation><mixed-citation xml:lang="en">Shenderov BA. PROBIOTICS AND FUNCTIONAL FOODS, in Food Engineering, [Eds. UNESCO-EOLSS Joint Committee], in Encyclopedia of Life Support Systems (EOLSS), Developed under the Auspices of the UNESCO, Eolss Publishers, Oxford, UK, [http://www.eols.net]. 2011; 33p.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Shenderov BA, Midtvedt T. Epigenomic programing: a future way to health? Microbial ecology in Health &amp; Disease 2014, 25: 24145 - http://dx.doi.org/10.3402/mehd.v25.24145.</mixed-citation><mixed-citation xml:lang="en">Shenderov BA, Midtvedt T. Epigenomic programing: a future way to health? Microbial ecology in Health &amp; Disease 2014, 25: 24145 - http://dx.doi.org/10.3402/mehd.v25.24145.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Stilling, R.M., Dinan, T.G., Cryan, J. F. Microbial genes, brain &amp; behavior - epigenetic regulation of the gut-brain axis. Genes Brain Behav. 2014; 13 (1): 69-86. doi: 10.1111/gbb.12109.</mixed-citation><mixed-citation xml:lang="en">Stilling, R.M., Dinan, T.G., Cryan, J. F. Microbial genes, brain &amp; behavior - epigenetic regulation of the gut-brain axis. Genes Brain Behav. 2014; 13 (1): 69-86. doi: 10.1111/gbb.12109.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Galand, L. The gut microbiome and the brain. J Med Food. - 2014. - Dec. - Vol. 17 (12): 1261-72. - doi: 10.1089/jmf.2014.7000.</mixed-citation><mixed-citation xml:lang="en">Galand, L. The gut microbiome and the brain. J Med Food. - 2014. - Dec. - Vol. 17 (12): 1261-72. - doi: 10.1089/jmf.2014.7000.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Sampson, T.R., Mazmanitan, S. K. Control of brain development, function, and behavior by the microbiome. Cell Host Microbe 2015; 17 (5): 565-576. doi: 0.1016/j.chom.2015.04.011.</mixed-citation><mixed-citation xml:lang="en">Sampson, T.R., Mazmanitan, S. K. Control of brain development, function, and behavior by the microbiome. Cell Host Microbe 2015; 17 (5): 565-576. doi: 0.1016/j.chom.2015.04.011.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Paul B., Barnes S., S. Demark-Wahnefried S, Morrow C, Salvador C, Skibola C, Tollrfboll OT. Influences of diet and the gut microbiome on epigenetic modulation in cancer and other diseases. Clinical Epigenetics 2015; 7.112. Doi:10.1186/s13148-015-0144-7.</mixed-citation><mixed-citation xml:lang="en">Paul B., Barnes S., S. Demark-Wahnefried S, Morrow C, Salvador C, Skibola C, Tollrfboll OT. Influences of diet and the gut microbiome on epigenetic modulation in cancer and other diseases. Clinical Epigenetics 2015; 7.112. Doi:10.1186/s13148-015-0144-7.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Oleskin A. V., El’-Registan G.I., Shenderov B. A. Mezhmikrobnyye khimicheskiye vzaimodeystviya i dialog mikrobiota-khozyain: rol’ neyromediatorov. Mikrobiologiya 2016; 85(1): 1-24.</mixed-citation><mixed-citation xml:lang="en">Oleskin A. V., El’-Registan G.I., Shenderov B. A. Mezhmikrobnyye khimicheskiye vzaimodeystviya i dialog mikrobiota-khozyain: rol’ neyromediatorov. Mikrobiologiya 2016; 85(1): 1-24.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Oleskin AV, Shenderov BA, Rogovsky VS. Role of Neurochemicals in the Interaction between the Microbiota and the Immune and the Nervous System of the Host Organism. Probiotics and Antimicrobial Proteins, February 2017. DOI: 10.1007/s12602-017-9262-1.</mixed-citation><mixed-citation xml:lang="en">Oleskin AV, Shenderov BA, Rogovsky VS. Role of Neurochemicals in the Interaction between the Microbiota and the Immune and the Nervous System of the Host Organism. Probiotics and Antimicrobial Proteins, February 2017. DOI: 10.1007/s12602-017-9262-1.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Shenderov BA. Metabiotics: novel idea or natural development of probiotic conception. Microb Ecol Health Dis 2013; 24: 20399-http:// dx.doi. org/10.3402/mehd.v24i0.20399.</mixed-citation><mixed-citation xml:lang="en">Shenderov BA. Metabiotics: novel idea or natural development of probiotic conception. Microb Ecol Health Dis 2013; 24: 20399-http:// dx.doi. org/10.3402/mehd.v24i0.20399.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Sharma M, Shukla G. Metabiotics: One Step ahead of Probiotics; an Insight into Mechanisms Involved in Anticancerous Effect in Colorectal Cancer. Front Microbiol 7:1940. Doi: 10.3389/fmicb.2016.01940.</mixed-citation><mixed-citation xml:lang="en">Sharma M, Shukla G. Metabiotics: One Step ahead of Probiotics; an Insight into Mechanisms Involved in Anticancerous Effect in Colorectal Cancer. Front Microbiol 7:1940. Doi: 10.3389/fmicb.2016.01940.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Beloborodova NV, Osipov GA. Small molecules originating from microbes (SMOM) and their role in microbes-host relationship. Microb Ecol Health Dis 2000; 12:12e21.</mixed-citation><mixed-citation xml:lang="en">Beloborodova NV, Osipov GA. Small molecules originating from microbes (SMOM) and their role in microbes-host relationship. Microb Ecol Health Dis 2000; 12:12e21.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Nicolson G. L., Mattos de G.F., Settineri R., Costa C., Ellithorpe R., Rosenblatt S., Valle La J., Jimenez A., Ohta S. Clinical effects of hydrogen administration: from animal and human diseases to exercise medicine. Intern J Clin Medicine 2016; 7: 32-76. doi.org/10.4236/ijcm.2016.71005</mixed-citation><mixed-citation xml:lang="en">Nicolson G. L., Mattos de G.F., Settineri R., Costa C., Ellithorpe R., Rosenblatt S., Valle La J., Jimenez A., Ohta S. Clinical effects of hydrogen administration: from animal and human diseases to exercise medicine. Intern J Clin Medicine 2016; 7: 32-76. doi.org/10.4236/ijcm.2016.71005</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Lazebnik L. B., Konev Yu. V. Mikrobiota tolstoy kishki i sostavlyayushchiye metabolicheskogo sindroma // Eksperimental’naya i klinicheskaya gastroenterologiya. - 2014. - № 5. - S. 33-39.</mixed-citation><mixed-citation xml:lang="en">Lazebnik L. B., Konev Yu. V. Mikrobiota tolstoy kishki i sostavlyayushchiye metabolicheskogo sindroma // Eksperimental’naya i klinicheskaya gastroenterologiya. - 2014. - № 5. - S. 33-39.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Ardatskaya M. D. Probiotiki, prebiotiki i metabiotiki v korrektsii mikroekologicheskikh narusheniy kishechnika. Meditsinskiy Sovet 2015; № 3: 94-9.</mixed-citation><mixed-citation xml:lang="en">Ardatskaya M. D. Probiotiki, prebiotiki i metabiotiki v korrektsii mikroekologicheskikh narusheniy kishechnika. Meditsinskiy Sovet 2015; № 3: 94-9.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, Salminen SJ. et al. The nternational scientific association for probiotics and prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nature Reviews Gastroenterology &amp; Hepatology. Published online 14 Jun 2017. Doi: 10.1038/nrgast6ro. 2017.75.</mixed-citation><mixed-citation xml:lang="en">Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, Salminen SJ. et al. The nternational scientific association for probiotics and prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nature Reviews Gastroenterology &amp; Hepatology. Published online 14 Jun 2017. Doi: 10.1038/nrgast6ro. 2017.75.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Nguen H-T, Truong D-H, Kouhonde S, Ly S, Razafindralambo H, Delvigne F. Biochemical engineering approaches for increasing viability and functionality of probiotic bacteria. Int J Mol Sci 2016 Jun 2; 17(6). pii: E867. Doi: 10.3390/ijms17060867.</mixed-citation><mixed-citation xml:lang="en">Nguen H-T, Truong D-H, Kouhonde S, Ly S, Razafindralambo H, Delvigne F. Biochemical engineering approaches for increasing viability and functionality of probiotic bacteria. Int J Mol Sci 2016 Jun 2; 17(6). pii: E867. Doi: 10.3390/ijms17060867.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Katan A. Why the European Food Safety Authority was right to reject health claims or probiotics. Benefitial Microbes; 2012. 3(2): 85-89.</mixed-citation><mixed-citation xml:lang="en">Katan A. Why the European Food Safety Authority was right to reject health claims or probiotics. Benefitial Microbes; 2012. 3(2): 85-89.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Hill C, Guarner F, Reid G, Gibson G, Merenstein D, Pot B, Morelli L. et al. The International scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014; 11(8): 506-514. Doi: 10.1038/nrgastro.2014.66.</mixed-citation><mixed-citation xml:lang="en">Hill C, Guarner F, Reid G, Gibson G, Merenstein D, Pot B, Morelli L. et al. The International scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014; 11(8): 506-514. Doi: 10.1038/nrgastro.2014.66.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Vakhitov T. Ya., Sitkin S. I. Kontseptsiya superorganizma v biologii i meditsine. Eksperimental’naya i klinicheskaya gastroenterologiya 2014; № 107 (7): 72-85.</mixed-citation><mixed-citation xml:lang="en">Vakhitov T. Ya., Sitkin S. I. Kontseptsiya superorganizma v biologii i meditsine. Eksperimental’naya i klinicheskaya gastroenterologiya 2014; № 107 (7): 72-85.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Vakhitov T. Yu., Petrov L. N., Bondarenko V. M. Kontseptsiya probioticheskogo preparata, soderzhashchego original’nyye mikrobnyye metabolity ZHMEI 2005; № 5: 108-114.</mixed-citation><mixed-citation xml:lang="en">Vakhitov T. Yu., Petrov L. N., Bondarenko V. M. Kontseptsiya probioticheskogo preparata, soderzhashchego original’nyye mikrobnyye metabolity ZHMEI 2005; № 5: 108-114.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Neish AS. Microbes in gastrointestinal health and disease.Gastroenterology 2009; 136: 65-80.</mixed-citation><mixed-citation xml:lang="en">Neish AS. Microbes in gastrointestinal health and disease.Gastroenterology 2009; 136: 65-80.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Sonnenburg JL, Fischbach MA. Community Health care: therapeutic opportunities in the human microbiome. Sci Transl Med 2011 Apr 13; 3(78): 78ps12. doi: 10.1126/scitranslmed. 3001626.</mixed-citation><mixed-citation xml:lang="en">Sonnenburg JL, Fischbach MA. Community Health care: therapeutic opportunities in the human microbiome. Sci Transl Med 2011 Apr 13; 3(78): 78ps12. doi: 10.1126/scitranslmed. 3001626.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Caselli M, Vaira G, Calo G, Papini F, Holton J, Vaira D. Structural bacterial molecules as potential candidates for an evolution of the classical concept of probiotics. Adv Nutr 2011; 2: 372-376.</mixed-citation><mixed-citation xml:lang="en">Caselli M, Vaira G, Calo G, Papini F, Holton J, Vaira D. Structural bacterial molecules as potential candidates for an evolution of the classical concept of probiotics. Adv Nutr 2011; 2: 372-376.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Thompson J. A., Oliveira R. A., Djukovic A., Ubeda C., Xavier K. B. Manipulation of the Quorum-Sensing Signal AI-2 Affects the Antibiotic-Treated Gut Microbiota. Cell Reports 2015; 10.</mixed-citation><mixed-citation xml:lang="en">Thompson J. A., Oliveira R. A., Djukovic A., Ubeda C., Xavier K. B. Manipulation of the Quorum-Sensing Signal AI-2 Affects the Antibiotic-Treated Gut Microbiota. Cell Reports 2015; 10.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Verbeke F, De Craemer S, Debunne N, Janssens Y, Wynendaele E, Van de Wiele C, De Spiegeleer B. Peptides as Quorum Sensing Molecules: Measurement Techniques and Obtained Levels In vitro and In vivo. Front. Neurosci. 2017;11:183. doi: 10.3389/fnins.2017.00183.</mixed-citation><mixed-citation xml:lang="en">Verbeke F, De Craemer S, Debunne N, Janssens Y, Wynendaele E, Van de Wiele C, De Spiegeleer B. Peptides as Quorum Sensing Molecules: Measurement Techniques and Obtained Levels In vitro and In vivo. Front. Neurosci. 2017;11:183. doi: 10.3389/fnins.2017.00183.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Kamada N, Nunez G. Regulation of the immune system by the resident intestinal bacteria. Gastroenterology 2014; 146(6): 1477-88.</mixed-citation><mixed-citation xml:lang="en">Kamada N, Nunez G. Regulation of the immune system by the resident intestinal bacteria. Gastroenterology 2014; 146(6): 1477-88.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Karczewski J, Poniedzialek B, Adamski Z, Rzymski P. The effects of the microbiota on the host immune system. Autoimmunity 2014. DOI: 10.3109/08916934.2014.938322.</mixed-citation><mixed-citation xml:lang="en">Karczewski J, Poniedzialek B, Adamski Z, Rzymski P. The effects of the microbiota on the host immune system. Autoimmunity 2014. DOI: 10.3109/08916934.2014.938322.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Blander J. M., Longman R. S., Iliev I. D., Sonnenberg G. F., Artis D. Regulation of inflammation by microbiota interactions with the host. Nature Immunology 2017; 18(6): 851-860.</mixed-citation><mixed-citation xml:lang="en">Blander J. M., Longman R. S., Iliev I. D., Sonnenberg G. F., Artis D. Regulation of inflammation by microbiota interactions with the host. Nature Immunology 2017; 18(6): 851-860.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Lebeer S., Bron P. A., Marco ML., Van Pijkeren J-P., O’Conell Motherway M., Hill C., Pot B., Roos S., Klaenhammer T. Identification of probiotic effector molecules: present state and future perspectives. Current Opinion in Biotechnology 2018; 49: 217-223.</mixed-citation><mixed-citation xml:lang="en">Lebeer S., Bron P. A., Marco ML., Van Pijkeren J-P., O’Conell Motherway M., Hill C., Pot B., Roos S., Klaenhammer T. Identification of probiotic effector molecules: present state and future perspectives. Current Opinion in Biotechnology 2018; 49: 217-223.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Wallace DC. The epigenome and the mitochondrion: bioenergetics and the environment. Gen Dev 2010; 24:1571-1573.</mixed-citation><mixed-citation xml:lang="en">Wallace DC. The epigenome and the mitochondrion: bioenergetics and the environment. Gen Dev 2010; 24:1571-1573.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Wallace B. D., Redinbo MT. The Human Microbiome is a Source of Therapeutic Drug Targets. Curr Opin Chem Biol 2013; 17(3):379-384. Doi:10.1016/j.cbpa.2013.04.011.</mixed-citation><mixed-citation xml:lang="en">Wallace B. D., Redinbo MT. The Human Microbiome is a Source of Therapeutic Drug Targets. Curr Opin Chem Biol 2013; 17(3):379-384. Doi:10.1016/j.cbpa.2013.04.011.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Gao D., Gao Z., Zhu G. Antioxidant effects of Lactobacillus plantarum via activation of transcription factor Nrf2. Food Funct 2013; 4:982-989.</mixed-citation><mixed-citation xml:lang="en">Gao D., Gao Z., Zhu G. Antioxidant effects of Lactobacillus plantarum via activation of transcription factor Nrf2. Food Funct 2013; 4:982-989.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Mishra V, Shah C, Mokashe N, Chavan R, Yadav H, Prajapati J. Probiotics as potential antioxidants: A systematic review. J. Agric Food Chem. 2015; 63: 3615-3626.</mixed-citation><mixed-citation xml:lang="en">Mishra V, Shah C, Mokashe N, Chavan R, Yadav H, Prajapati J. Probiotics as potential antioxidants: A systematic review. J. Agric Food Chem. 2015; 63: 3615-3626.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Prosekov A., Dyshlyuk L., Milentyeva I, Sukhish S, Babich O, Ivanova S, Pavskyi V., Shishin M., Matskova L. Antioxidant, antimicrobial and antitumor activity of bacteria of the genus bifidobacterium, selected from the gastrointestinal tract of human. Integr Mol Med 2015; 2(5): 295-303.</mixed-citation><mixed-citation xml:lang="en">Prosekov A., Dyshlyuk L., Milentyeva I, Sukhish S, Babich O, Ivanova S, Pavskyi V., Shishin M., Matskova L. Antioxidant, antimicrobial and antitumor activity of bacteria of the genus bifidobacterium, selected from the gastrointestinal tract of human. Integr Mol Med 2015; 2(5): 295-303.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Jones RM., Neish A. S. Redox signaling mediated by the gut microbiota. Free Radical Biology and Medicine 2017; 105: 41-47 http://dx.doi.org/10.1016/j.freeradbiomed.2016.10.495.</mixed-citation><mixed-citation xml:lang="en">Jones RM., Neish A. S. Redox signaling mediated by the gut microbiota. Free Radical Biology and Medicine 2017; 105: 41-47 http://dx.doi.org/10.1016/j.freeradbiomed.2016.10.495.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Wang Y., Wu Y., Wang Y., Xu H, Mei X, Yu D, Wang Y, Li W. Antioxidant Properties of Probiotic Bacteria. Nutrients 2017; 9:521; doi: 10.3390/nu9050521.</mixed-citation><mixed-citation xml:lang="en">Wang Y., Wu Y., Wang Y., Xu H, Mei X, Yu D, Wang Y, Li W. Antioxidant Properties of Probiotic Bacteria. Nutrients 2017; 9:521; doi: 10.3390/nu9050521.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Shenderov B. A. Mikroekologicheskaya epigenetika stressa, zabolevaniy, zdorov’ya i dolgoletiya. Vestnik vosstanovitel’noy meditsiny 2016; № 1: 21-8.</mixed-citation><mixed-citation xml:lang="en">Shenderov B. A. Mikroekologicheskaya epigenetika stressa, zabolevaniy, zdorov’ya i dolgoletiya. Vestnik vosstanovitel’noy meditsiny 2016; № 1: 21-8.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">El Aidy S, Stilling R. M. Dinan T. G., Cryan J. T. Microbiome to Brain: Unravelling the multidirectional axes of communication. Microbial Endocrinology: Interkingdom signaling in infectious disease and health. M. Lyte (ed). Advances in Experimental Medicine and Biology. Chapter 15. Springer International Publishing AG 2016: 301-336. Doi: 10.1007/978-3-319-20215_15.</mixed-citation><mixed-citation xml:lang="en">El Aidy S, Stilling R. M. Dinan T. G., Cryan J. T. Microbiome to Brain: Unravelling the multidirectional axes of communication. Microbial Endocrinology: Interkingdom signaling in infectious disease and health. M. Lyte (ed). Advances in Experimental Medicine and Biology. Chapter 15. Springer International Publishing AG 2016: 301-336. Doi: 10.1007/978-3-319-20215_15.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Shenderov BA (2016) The microbiota as an epigenetic control mechanism. Chapter 11. In: Nibali L, Henderson B (eds) The human microbiota and chronic disease: dysbiosis as a cause of human pathology. 1st ed, J. Wiley &amp; Sons, pp.179-197.</mixed-citation><mixed-citation xml:lang="en">Shenderov BA (2016) The microbiota as an epigenetic control mechanism. Chapter 11. In: Nibali L, Henderson B (eds) The human microbiota and chronic disease: dysbiosis as a cause of human pathology. 1st ed, J. Wiley &amp; Sons, pp.179-197.</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Legent G, Norris V. Hybolites: novel therapeutic toolsfor targeting hyperstructure in bacteria. Recent Pat on Antiinfect Drug Discov 2009; 4 (2): 90-5.</mixed-citation><mixed-citation xml:lang="en">Legent G, Norris V. Hybolites: novel therapeutic toolsfor targeting hyperstructure in bacteria. Recent Pat on Antiinfect Drug Discov 2009; 4 (2): 90-5.</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Norris V, Verrier C, Feuilloley M. Hybolites Revisited. Recent Pat on Antiinfect Drug Discov 2016; 11 (1): 1-13. Send Orders for Reprints to reprints@ benyhamscience.ae.</mixed-citation><mixed-citation xml:lang="en">Norris V, Verrier C, Feuilloley M. Hybolites Revisited. Recent Pat on Antiinfect Drug Discov 2016; 11 (1): 1-13. Send Orders for Reprints to reprints@ benyhamscience.ae.</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Kashyap P. C., Chia N., Nelson H., Segal E., Elinav E. Microbiome at the Frontier of Personalized Medicine. Mayo Clin Proc 2017; 92(12): 1855-1864. https://doi.org/10.1016/j.mayocp.2017.10.004.</mixed-citation><mixed-citation xml:lang="en">Kashyap P. C., Chia N., Nelson H., Segal E., Elinav E. Microbiome at the Frontier of Personalized Medicine. Mayo Clin Proc 2017; 92(12): 1855-1864. https://doi.org/10.1016/j.mayocp.2017.10.004.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
